AAMU
TXG icon

Amundi Asset Management US’s 10x Genomics TXG Stock Holding History

Amundi Asset Management US’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$33.2M Buy
183,679
+9,416
+5% +$1.63M 0.03% 529
2020
Q4 		$24.7M Sell
174,263
-10,764
-6% -$1.56M 0.02% 575
2020
Q3 		$23.1M Buy
185,027
+15,635
+9% +$1.64M 0.02% 506
2020
Q2 		$15.1M Buy
169,392
+113,219
+202% +$8.82M 0.02% 590
2020
Q1 		$3.5M Sell
56,173
-14,686
-21% -$1.15M 0.01% 826
2019
Q4 		$5.4M Buy
+70,859
New +$4.26M 0.01% 895

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Amundi Asset Management US's TXG Position: Q1 2021 in Review

Amundi Asset Management US increased its 10x Genomics (TXG) stake by 5.4% in Q1 2021, buying an estimated $1.63M and bringing the position to 183,679 shares worth $33.2M. The position accounts for 0.03% of the portfolio, ranked #529.

Amundi Asset Management US first reported a position in TXG in Q4 2019 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold TXG as of Q1 2021.

  • Amundi Asset Management US held 183,679 shares of 10x Genomics worth $33.2M as of Q1 2021.
  • Amundi Asset Management US bought 9,416 10x Genomics shares in Q1 2021, an estimated $1.63M.
  • 10x Genomics made up 0.03% of Amundi Asset Management US's portfolio in Q1 2021, its #529 holding.
  • Amundi Asset Management US first reported a position in 10x Genomics in Q4 2019 and has held it in 6 quarters since.
  • 324 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.